Please use this identifier to cite or link to this item:
Title: A case study: Analysis of patents on coronaviruses and covid-19 for technological assessment and future research
Authors: Musyuni P
Aggarwal G
Nagpal M
Goyal R K
Keywords: Coronaviruses (CoV)
COVID-19 (2019-nCoV)
patent analysis
research evaluation
technology assessment.
Issue Date: 2021
Publisher: Current Pharmaceutical Design
Abstract: Background: Protecting intellectual property rights are important and particularly pertinent for inventions that are an outcome of rigorous research and development. While the grant of patents is subject to establishing novelty and inventive step, it further indicates the technological development and is helpful for researchers working in the same technical domain. The aim of the present research work is to map the existing work through an analysis of patent literature in the field of Coronaviruses (CoV), particularly COVID-19 (2019-nCoV). CoV is a large family of viruses known to cause illness in humans and animals, particularly known for causing respiratory infections, as evidenced in earlier times, such as in MERS i.e., Middle East Respiratory Syndrome; and SRS i.e., Severe Acute Respiratory Syndrome. A recently identified novel-coronavirus, known as COVID-19, has caused pandemic situations across the globe.
URI: 10.2174/1381612826666200720233947
Appears in Collections:Journals

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.